Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others... Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge. Mehr anzeigen
Curis Provides Third Quarter 2024 Business Update PR Newswire LEXINGTON, Mass., Nov. 14, 2024 Management to host conference call today at 8:30 a.m. ET LEXINGTON, Mass., Nov. 14, 2024 /PRNewswire/...
Curis to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on November 14, 2024 PR Newswire LEXINGTON, Mass., Nov. 7, 2024 LEXINGTON, Mass., Nov. 7...
Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement PR Newswire LEXINGTON, Mass., Oct. 29, 2024 LEXINGTON, Mass., Oct. 29, 2024 /PRNewswire/ -- Curis, Inc. ("Curis...
Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer PR Newswire LEXINGTON, Mass., Sept. 23, 2024 Symposium hosted by Eric S. Winer, MD, and Grzegorz S. Nowakowski, MD Updated data for 10...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.22 | 5.77427821522 | 3.81 | 4.3499 | 3.6 | 87776 | 4.02265737 | CS |
| 4 | -0.58 | -12.5813449024 | 4.61 | 5 | 3.51 | 87019 | 4.14983774 | CS |
| 12 | -1.15 | -22.2007722008 | 5.18 | 6.44 | 3.51 | 51562 | 4.63714942 | CS |
| 26 | -7.3141 | -64.4749252916 | 11.3441 | 11.4 | 3.51 | 48237 | 5.56851524 | CS |
| 52 | -4.62 | -53.4104046243 | 8.65 | 17.49 | 3.51 | 46280 | 8.68329655 | CS |
| 156 | -97.57 | -96.0334645669 | 101.6 | 105.4 | 3.51 | 932314 | 31.90551397 | CS |
| 260 | -33.97 | -89.3947368421 | 38 | 348 | 3.51 | 1557521 | 97.28162405 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
